Influence of Radiotherapy Technique and Dose on Patterns of Failure for Mesothelioma Patients After Extrapleural Pneumonectomy

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 5, 2007, Pages 1366-1374

  Allen, Aaron M ^a,b   Den, Robert ^a,b   Wong, Julia S ^a,b   Zurakowski, David ^c   Soto, Ricardo ^a,b   Jänne, Pasi A ^a,b   Zellos, Lambros ^a   Bueno, Raphael ^a   Sugarbaker, David J ^b   Baldini, Elizabeth H ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Extrapleural pneumonectomy; Mesothelioma; Radiotherapy

Indexed keywords

BIOMEDICAL ENGINEERING; DISEASES; FAILURE ANALYSIS; RADIATION EFFECTS;

EXTRAPLEURAL PNEUMONECTOMY; MESOTHELIOMA; PHOTON/ELECTRON TECHNIQUES;

RADIOTHERAPY;

CARBOPLATIN; CISPLATIN; GEMCITABINE; PACLITAXEL; PEMETREXED;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CONFIDENCE INTERVAL; ELECTRON; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LOW DRUG DOSE; LUNG RESECTION; LYMPH NODE; MEDIASTINUM; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PHOTON; PLEURA MESOTHELIOMA; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIATION DOSE; UNIVARIATE ANALYSIS;

ADULT; AGED; ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; PNEUMONECTOMY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 34547492255     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.02.047     Document Type: Article

References (18)

1. Yajnik S., Rosenzweig K.E., Mychalczak B., et al. Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 56 (2003) 1319-1326
2. Grondin S.C., and Sugarbaker D.J. Malignant mesothelioma of the pleural space. Oncology (Williston Park) 13 (1999) 919-931
3. Vogelzang N.J., Rusthoven J.J., Symanowski J., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (2003) 2636-2644
4. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients. J Thorac Cardiovasc Surg 117 (1999) 54-63
5. Baldini E.H., Recht A., Strauss G.M., et al. Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 63 (1997) 334-338
6. Sugarbaker D.J., Strauss G.M., Lynch T.J., et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 11 (1993) 1172-1178
7. Kaplan E.L. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
8. Kalbfleisch J.D., and Prentice R.L. The statistical analysis of failure time data (1980), John Wiley, New York
9. Rusch V.W., Piantadosi S., and Holmes E.C. The role of extrapleural pneumonectomy in malignant pleural mesothelioma: A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg 102 (1991) 1-9
10. Sugarbaker D.J., Jaklitsch M.T., Bueno R., et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 128 (2004) 138-146
11. Keller S.M., Adak S., Wagner H., et al., Eastern Cooperative Oncology Group. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. N Engl J Med 343 (2000) 1217-1222
12. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
13. Rusch V.W., Rosenzweig K., Venkatraman E., et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122 (2001) 788-795
14. Ahamad A., Stevens C.W., Smythe W.R., et al. Intensity-modulated radiation therapy: A novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 55 (2003) 768-775
15. Ahamad A., Stevens C.W., Smythe W.R., et al. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J 9 (2003) 476-484
16. Kindler H.L. Malignant pleural mesothelioma. Curr Treat Options Oncol 1 (2000) 313-326
17. Nowak A.K., Byrne M.J., Williamson R., et al. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma. Br J Cancer 87 (2002) 491-496
18. van Haarst J.M., Baas P., Manegold C., et al. Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma. Br J Cancer 86 (2002) 342-345